Exact Sciences Corp (NASDAQ:EXAS) shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the details from the report.  The Details: Exact Sciences reported quarterly losses of 9 cents per share, which beat the analyst consensus estimate of losses of 32 cents by 71.88%. The company reported quarterly sales of $699.264 million which beat the analyst consensus estimate of $690.003 million and is a 12.41% increase over sales from the same period last year. Screening revenue was $532 million, a ...